Cardiosense

Private

Chicago, IllinoisHealthcare & Life Scienceshttps://cardiosense.com/

Last Round

Series A

Dec 8, 2022

Total Funding Raised

$15.1M

Company Overview

Cardiosense is a digital health company that develops a physiological waveform AI platform and multi-sensor devices to enable early detection and management of cardiovascular disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Healthcare Analytics, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

heart failure managementnoninvasive PCWP estimationcardiac monitoringmedical-grade wearablePulmonary Capillary Wedge PressurePCWPphysiological waveform AIremote patient monitoringRPMmedical AIseismocardiographyhemodynamic monitoringMedTechdigital biomarkersFDA Breakthrough DeviceHealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cardiosense Comparables

Compare Cardiosense with similar companies based on industry and business-model similarity.

Cardiosense comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Maxim Integrated	76%
CorVista Health	76%
Biotricity Inc	74%

View all Comparables

Cardiosense Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 8, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Omer Inan

Chief Scientific Officer, Co-Founder, And Board Member

Founding Team

Eric Meizlish

Chief Executive Officer

Executive Team

Ehud Gelblum

Fractional Chief Financial Officer

Executive Team

Cardiosense Investors

Notable investors and investment history

Cardiosense investors
Investor	Rounds
UnityPoint Health Ventures	Series A
Hatteras Venture Partners	Series A
OSF Ventures	Series A
Portal Innovations	Series A
Broadview Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 12, 2025
Monthly visitors increased 41% MoM, reaching 2.6K.
May 4, 2025
Monthly visitors increased 135% MoM, reaching 6.1K.

View all signals

Cardiosense Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cardiosense Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cardiosense's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois

Employee Range38

Year Founded2020

Last FundingDec 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.